Extended duration local anesthetic agent in a rat paw model

  • D. E. Ickowicz
  • , L. Golovanevski
  • , A. J. Domb
  • , C. F. Weiniger

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Encapsulated local anesthetics extend postoperative analgesic effect following site-directed nerve injection; potentially reducing postoperative complications. Our study aim was to investigate efficacy of our improved extended duration formulation - 15% bupivacaine in poly(DL-lactic acid co castor oil) 3:7 synthesized by ring opening polymerization. In vitro, around 70% of bupivacaine was released from the p(DLLA-CO) 3:7 after 10 days. A single injection of the optimal formulation of 15% bupivacaine-polymer or plain (0.5%) bupivacaine (control), was injected via a 22G needle beside the sciatic nerve of Sprague-Dawley rats under anesthesia; followed (in some animals) by a 1 cm longitudinal incision through the skin and fascia of the paw area. Behavioral tests for sensory and motor block assessment were done using Hargreave's hot plate score, von Frey filaments and rearing count. The 15% bupivacaine formulation significantly prolonged sensory block duration up to at least 48 h. Following surgery, motor block was observed for 48 h following administration of bupivacaine-polymer formulation and rearing was reduced (returning to baseline after 48 h). No significant differences in mechanical nociceptive response were observed. The optimized bupivacaine-polymer formulation prolonged duration of local anesthesia effect in our animal model up to at least 48 h.

Original languageEnglish
Pages (from-to)152-157
Number of pages6
JournalInternational Journal of Pharmaceutics
Volume468
Issue number1-2
DOIs
StatePublished - 1 Jul 2014
Externally publishedYes

Bibliographical note

Funding Information:
The author (CFW) is supported by the Legacy Heritage Science Initiative Program of the Israel Science Foundation (1637/10). No fund was receieved from the National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI), Medical Research Council (MRC), and/or Wellcome Trust.

Funding

The author (CFW) is supported by the Legacy Heritage Science Initiative Program of the Israel Science Foundation (1637/10). No fund was receieved from the National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI), Medical Research Council (MRC), and/or Wellcome Trust.

FundersFunder number
National Institutes of Health
Howard Hughes Medical Institute
Wellcome Trust
Medical Research Council
Israel Science Foundation1637/10

    Keywords

    • Bupivacaine
    • Injectable local anesthetics
    • Polymer
    • Prolonged release

    Fingerprint

    Dive into the research topics of 'Extended duration local anesthetic agent in a rat paw model'. Together they form a unique fingerprint.

    Cite this